Medullary tyrosine hydroxylase catecholaminergic neuronal populations in sudden unexpected death in epilepsy.


Journal

Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781

Informations de publication

Date de publication:
01 2021
Historique:
received: 08 04 2020
revised: 12 06 2020
accepted: 06 08 2020
pubmed: 28 8 2020
medline: 21 12 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Sudden unexpected death in epilepsy (SUDEP) is mechanistically complex and one probable cause is seizure-related respiratory dysfunction. Medullary respiratory regulatory nuclei include the pre-Bötzinger complex (pre-BötC) in the ventrolateral medulla (VLM), the medullary raphé nuclei (MR) and nucleus of solitary tract in the dorsomedial medulla (DMM). The region of the VLM also contains intermingled tyrosine hydroxylase (TH) catecholaminergic neurones which directly project to the pre-BötC and regulate breathing under hypoxic conditions and our aim was to evaluate these neurones in SUDEP cases. In post-mortem cases from three groups [SUDEP (18), epilepsy controls (8) and non-epilepsy controls (16)] serial sections of medulla (obex + 2 to + 13 mm) were immunolabeled for TH. Three regions of interest (ROI) were outlined (VLM, DMM and MR) and TH-immunoreactive (TH-IR) neurones were evaluated using automated detection for overall labeling index (neurones and processes) and neuronal densities and compared between groups and relative to obex level. C-fos immunoreactivity was also semi-quantitatively evaluated in these regions. We found no significant difference in the density of TH-IR neurones or labeling index between the groups in all regions. Significantly more TH-IR neurones were present in the DMM region than VLM in non-epilepsy cases only (P < 0.01). Regional variations in TH-IR neurones with obex level were seen in all groups except SUDEP. We also identified occasional TH neurones in the MR region in all groups. There was significantly less c-fos labeling in the VLM and MR in SUDEP than non-epilepsy controls but no difference with epilepsy controls. In conclusion, in this series we found no evidence for alteration of total medullary TH-IR neuronal numbers in SUDEP but noted some differences in their relative distribution in the medulla and c-fos neurones compared to control groups which may be relevant to the mechanism of death.

Identifiants

pubmed: 32852867
doi: 10.1111/bpa.12891
pmc: PMC8018054
doi:

Substances chimiques

Tyrosine 3-Monooxygenase EC 1.14.16.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-143

Subventions

Organisme : Medical Research Council
ID : G0701018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1100578
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N004272/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS090415
Pays : United States
Organisme : NINDS NIH HHS
ID : 5U01NS090415
Pays : United States
Organisme : Department of Health [UK]
Organisme : NINDS NIH HHS
ID : U01 NS090405
Pays : United States

Informations de copyright

© 2020 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Références

Neuroimage Clin. 2018 Jul 18;20:205-215
pubmed: 30094170
Dev Biol. 1991 Nov;148(1):10-22
pubmed: 1682190
Brain. 2018 Jun 1;141(6):1719-1733
pubmed: 29608654
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):659-78
pubmed: 16741673
Neuroscience. 1996 Aug;73(3):807-16
pubmed: 8809800
Early Hum Dev. 2003 Dec;75 Suppl:S41-50
pubmed: 14693390
Microsc Res Tech. 1999 Jul 1;46(1):24-47
pubmed: 10402270
Neurology. 2019 Jan 15;92(3):e171-e182
pubmed: 30568003
Lancet Neurol. 2013 Oct;12(10):966-77
pubmed: 24012372
J Neurosci Methods. 2019 Oct 1;326:108368
pubmed: 31356836
Epilepsia. 2017 Jan;58(1):17-26
pubmed: 27888514
Front Neurol. 2018 Sep 26;9:793
pubmed: 30319527
Neuroscience. 1988 Apr;25(1):97-111
pubmed: 2899306
Epilepsy Res. 2000 Mar;39(1):1-12
pubmed: 10690748
Lancet Neurol. 2016 Sep;15(10):1075-88
pubmed: 27571159
Pediatrics. 1998 Feb;101(2):285-8
pubmed: 9445505
Hypertension. 2013 Apr;61(4):835-41
pubmed: 23438930
Front Neurol. 2016 Jun 27;7:93
pubmed: 27445960
J Comp Neurol. 2012 Aug 1;520(11):2352-68
pubmed: 22237784
Prog Neurobiol. 1996 Oct;50(2-3):83-107
pubmed: 8971979
Front Neurol. 2019 Mar 05;10:185
pubmed: 30891003
Epilepsy Behav. 2010 Oct;19(2):167-71
pubmed: 20709604
J Chem Neuroanat. 1996 Apr;10(2):137-46
pubmed: 8783042
J Neurol. 2017 Nov;264(11):2249-2257
pubmed: 28939940
Brain Res. 1995 Jan 9;669(1):145-9
pubmed: 7712159
Front Neurol. 2017 May 18;8:210
pubmed: 28572789
PLoS One. 2015 Jun 18;10(6):e0130822
pubmed: 26087133
Front Cell Neurosci. 2015 Mar 12;9:72
pubmed: 25814929
Brain. 2009 Jul;132(Pt 7):1810-9
pubmed: 19429902
Brain. 2005 Feb;128(Pt 2):338-44
pubmed: 15634729
Paediatr Respir Rev. 2014 Dec;15(4):293-300
pubmed: 25304427
Exp Neurol. 2017 Jan;287(Pt 2):165-175
pubmed: 27240519
J Appl Physiol (1985). 2016 Jun 1;120(11):1277-87
pubmed: 26968026
J Comp Neurol. 1999 Aug 16;411(1):145-61
pubmed: 10404113
Epilepsia. 2018 Mar;59(3):573-582
pubmed: 29336036
Neuroscience. 2017 May 20;351:1-14
pubmed: 28363783
Neuropediatrics. 1993 Feb;24(1):25-9
pubmed: 8097300
Front Neurol. 2019 May 14;10:501
pubmed: 31139142
Forensic Sci Int. 2002 Sep 14;130 Suppl:S53-9
pubmed: 12350301
Seizure. 2018 Dec;63:7-13
pubmed: 30391664
Methods Enzymol. 2018;603:197-220
pubmed: 29673526
Hum Brain Mapp. 2018 Dec;39(12):4820-4830
pubmed: 30096213
Epilepsia. 2016 Oct;57(10):1709-1718
pubmed: 27549906
Life Sci. 2003 Jul 25;73(10):1315-31
pubmed: 12850246
Am J Physiol Regul Integr Comp Physiol. 2013 Aug 1;305(3):R187-204
pubmed: 23697799

Auteurs

Smriti Patodia (S)

Department of Clinical and Experimental epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 2BG, UK.

Ian Tan (I)

Department of Clinical and Experimental epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 2BG, UK.

Matthew Ellis (M)

School of Cancer Sciences, University of Southampton, Southampton, UK.

Alyma Somani (A)

Department of Clinical and Experimental epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 2BG, UK.

Ingrid E Scheffer (IE)

Epilepsy Research Centre, Department of Medicine (Neurology), University of Melbourne, Victoria, 3052, Australia.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 2BG, UK.
Chalfont Centre for Epilepsy, Bucks, SL9 0RJ, UK.

Maria Thom (M)

Department of Clinical and Experimental epilepsy, UCL Queen Square Institute of Neurology, London, WC1N 2BG, UK.
School of Cancer Sciences, University of Southampton, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH